Digital Pathology Market Overview
Digital Pathology helps improve lab efficiency by reducing costs, decreasing turnaround times, and providing users with access to subject-matter expertise. Improvements in lab efficiency are critical as patients and physicians are hooked to lab results for diagnostic decisions, and diagnostic tests are required to be completed and reported quickly and accurately. At a predicted CAGR of 12.6% over the projection period, the global market for Digital Pathology is expected to increase from $892.5 million in 2022 to $2,045.9 million in 2029.
Moreover, access to digital slides via web services eliminates shipping costs and pathologists’ time period. The outbreak of the COVID-19 pandemic has led to the implementation of lockdowns and social distancing restrictions. Such restrictions have increased the demand for digital pathology solutions, as these are often employed by pathologists to remotely view diagnostic results for primary diagnosis. So as to achieve a competitive edge and deliver quick services, an outsized number of pathologists and pathology labs are adopting digital pathology.
Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them. The high cost of those systems, including a scarcity of skilled personnel to work digital pathology systems, is predicted to limit the adoption of those systems.
Covid-19 Impact on Digital Pathology Market:
In addition, the current Global Market study offers a detailed analysis of the current COVID-19 pandemic's impact on market growth and its influence on the future growth of the Global Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, and regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2022 and its projection up to 2029 is provided in detail in this report.
Digital Pathology Market Segment Overview
By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the biggest share of the worldwide digital pathology market in 2023. The massive share of this segment is often attributed to the increasing adoption of digital pathology solutions across the world.
By end-users, the worldwide digital pathology market is broadly segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the most important share of the worldwide digital pathology market in 2023. The massive share of this segment is often attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing.
By application, the digital pathology market is segmented into drug discovery, disease diagnosis, teleconsultation, and training & education. The drug discovery segment accounted for the most important share of the worldwide digital pathology market, by application, in 2023. The massive share of this segment is often attributed to the expansion in R&D expenditure, fuelled by the necessity for varied preclinical and clinical studies performed during the drug discovery and development process.
Market Analysis, Insights and Forecast – By Product
· Scanners
· Software
· Communication Systems
· Storage Systems
Market Analysis, Insights and Forecast – By End Use
· Pharmaceutical & Biotechnology Companies
· Hospitals and Reference Laboratories
· Academic & Research Institutes
Market Analysis, Insights and Forecast – By Application
· Drug Discovery
· Disease Diagnosis
· Teleconsultation
· Training & Education
Digital Pathology Market Regional Overview
Region-wise, in terms of regions, North America dominated the digital pathology market and held the biggest revenue share of over the forecast period. Continual deployment of R&D investments, supportive government initiatives concerning the event of technologically advanced systems, raising adoption of digital imaging, and therefore the presence of major players are the key contributing factors to this dominance. Increased usage of digital pathology for disease diagnosis including favorable reimbursement policies within the U.S., and improving the standard of cancer diagnosis, is predicted to further fuel the regional growth.
In the Asia Pacific, the marketplace for digital pathology is predicted to expand at a CAGR of during the forecast period because of the rising penetration of digital imaging in emerging economies, investments within the medical field, and therefore the presence of untapped opportunities. Asia Pacific's healthcare industry has highly influenced the market because of the increased incidence of cancer, which affects an outsized population. Also, increasing demand for novel treatment options, better patient care facilities, and a discount on laboratory expenses are expected to further drive the demand.
Digital Pathology Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Digital Pathology Market Competitor overview
Some key developments and strategies adopted by manufacturers in Digital Pathology are highlighted below.
· In June 2018, acquired Irish PathXL, one of the biggest pathology image-based analysis firms. This acquisition was administered to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics.
Digital Pathology Market, Key Players
· Hamamatsu Photonics, Inc.
· Koninklijke Philips N.V.
· Olympus Corporation
· F. Hoffmann-La Roche Ltd.
· Mikroscan Technologies
· Inspirata, Inc.
· Visiopharm A/S
· Huron Digital Pathology
· 3DHISTECH Ltd.
· ContextVision AB.
· Danaher
Digital Pathology helps improve lab efficiency by reducing costs, decreasing turnaround times, and providing users with access to subject-matter expertise. Improvements in lab efficiency are critical as patients and physicians are hooked to lab results for diagnostic decisions, and diagnostic tests are required to be completed and reported quickly and accurately. At a predicted CAGR of 12.6% over the projection period, the global market for Digital Pathology is expected to increase from $892.5 million in 2022 to $2,045.9 million in 2029.
Moreover, access to digital slides via web services eliminates shipping costs and pathologists’ time period. The outbreak of the COVID-19 pandemic has led to the implementation of lockdowns and social distancing restrictions. Such restrictions have increased the demand for digital pathology solutions, as these are often employed by pathologists to remotely view diagnostic results for primary diagnosis. So as to achieve a competitive edge and deliver quick services, an outsized number of pathologists and pathology labs are adopting digital pathology.
Although large hospitals with significant capital budgets can afford these systems, pathologists and academic institutes with limited budgets or IT support often cannot afford them. The high cost of those systems, including a scarcity of skilled personnel to work digital pathology systems, is predicted to limit the adoption of those systems.
Covid-19 Impact on Digital Pathology Market:
In addition, the current Global Market study offers a detailed analysis of the current COVID-19 pandemic's impact on market growth and its influence on the future growth of the Global Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, and regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2022 and its projection up to 2029 is provided in detail in this report.
Digital Pathology Market Segment Overview
By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the biggest share of the worldwide digital pathology market in 2023. The massive share of this segment is often attributed to the increasing adoption of digital pathology solutions across the world.
By end-users, the worldwide digital pathology market is broadly segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical & biotechnology companies segment accounted for the most important share of the worldwide digital pathology market in 2023. The massive share of this segment is often attributed to the increasing use of digital pathology for drug discovery studies and drug toxicology testing.
By application, the digital pathology market is segmented into drug discovery, disease diagnosis, teleconsultation, and training & education. The drug discovery segment accounted for the most important share of the worldwide digital pathology market, by application, in 2023. The massive share of this segment is often attributed to the expansion in R&D expenditure, fuelled by the necessity for varied preclinical and clinical studies performed during the drug discovery and development process.
Market Analysis, Insights and Forecast – By Product
· Scanners
· Software
· Communication Systems
· Storage Systems
Market Analysis, Insights and Forecast – By End Use
· Pharmaceutical & Biotechnology Companies
· Hospitals and Reference Laboratories
· Academic & Research Institutes
Market Analysis, Insights and Forecast – By Application
· Drug Discovery
· Disease Diagnosis
· Teleconsultation
· Training & Education
Digital Pathology Market Regional Overview
Region-wise, in terms of regions, North America dominated the digital pathology market and held the biggest revenue share of over the forecast period. Continual deployment of R&D investments, supportive government initiatives concerning the event of technologically advanced systems, raising adoption of digital imaging, and therefore the presence of major players are the key contributing factors to this dominance. Increased usage of digital pathology for disease diagnosis including favorable reimbursement policies within the U.S., and improving the standard of cancer diagnosis, is predicted to further fuel the regional growth.
In the Asia Pacific, the marketplace for digital pathology is predicted to expand at a CAGR of during the forecast period because of the rising penetration of digital imaging in emerging economies, investments within the medical field, and therefore the presence of untapped opportunities. Asia Pacific's healthcare industry has highly influenced the market because of the increased incidence of cancer, which affects an outsized population. Also, increasing demand for novel treatment options, better patient care facilities, and a discount on laboratory expenses are expected to further drive the demand.
Digital Pathology Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Digital Pathology Market Competitor overview
Some key developments and strategies adopted by manufacturers in Digital Pathology are highlighted below.
· In June 2018, acquired Irish PathXL, one of the biggest pathology image-based analysis firms. This acquisition was administered to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics.
Digital Pathology Market, Key Players
· Hamamatsu Photonics, Inc.
· Koninklijke Philips N.V.
· Olympus Corporation
· F. Hoffmann-La Roche Ltd.
· Mikroscan Technologies
· Inspirata, Inc.
· Visiopharm A/S
· Huron Digital Pathology
· 3DHISTECH Ltd.
· ContextVision AB.
· Danaher
| Report Metric | Details |
| Market size available for years | 2022–2029 |
| Base year considered | 2021 |
| Forecast period | 2022–2029 |
| Forecast unit | Value (USD Million) |
| Segments Covered | Product, End Use, Application, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Hamamatsu Photonics, Inc.,Koninklijke Philips N.V.,Olympus Corporation,F. Hoffmann-La Roche Ltd.,Mikroscan Technologies,Inspirata, Inc.,Visiopharm A/S,Huron Digital Pathology,3DHISTECH Ltd.,ContextVision AB.,· Danaher |
Digital Pathology Market Study Global Market Analysis, Insights and Forecast, 2022-2029
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Digital Pathology Market Analysis (USD Billion), Insights and Forecast, 2022-2029
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Scanners
- 5.2.2. Software
- 5.2.3. Communication Systems
- 5.2.4. Storage Systems
- 5.3. Market Analysis, Insights and Forecast – By End Use
- 5.3.1. Pharmaceutical & Biotechnology Companies
- 5.3.2. Hospitals and Reference Laboratories
- 5.3.3. Academic & Research Institutes
- 5.4. Market Analysis, Insights and Forecast – By Application
- 5.4.1. Drug Discovery
- 5.4.2. Disease Diagnosis
- 5.4.3. Teleconsultation
- 5.4.4. Training & Education
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Digital Pathology Market Analysis (USD Billion), Insights and Forecast, 2022-2029
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Scanners
- 6.2.2. Software
- 6.2.3. Communication Systems
- 6.2.4. Storage Systems
- 6.3. Market Analysis, Insights and Forecast – By End Use
- 6.3.1. Pharmaceutical & Biotechnology Companies
- 6.3.2. Hospitals and Reference Laboratories
- 6.3.3. Academic & Research Institutes
- 6.4. Market Analysis, Insights and Forecast – By Application
- 6.4.1. Drug Discovery
- 6.4.2. Disease Diagnosis
- 6.4.3. Teleconsultation
- 6.4.4. Training & Education
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Digital Pathology Market Analysis (USD Billion), Insights and Forecast, 2022-2029
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Scanners
- 7.2.2. Software
- 7.2.3. Communication Systems
- 7.2.4. Storage Systems
- 7.3. Market Analysis, Insights and Forecast – By End Use
- 7.3.1. Pharmaceutical & Biotechnology Companies
- 7.3.2. Hospitals and Reference Laboratories
- 7.3.3. Academic & Research Institutes
- 7.4. Market Analysis, Insights and Forecast – By Application
- 7.4.1. Drug Discovery
- 7.4.2. Disease Diagnosis
- 7.4.3. Teleconsultation
- 7.4.4. Training & Education
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Digital Pathology Market Analysis (USD Billion), Insights and Forecast, 2022-2029
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Scanners
- 8.2.2. Software
- 8.2.3. Communication Systems
- 8.2.4. Storage Systems
- 8.3. Market Analysis, Insights and Forecast – By End Use
- 8.3.1. Pharmaceutical & Biotechnology Companies
- 8.3.2. Hospitals and Reference Laboratories
- 8.3.3. Academic & Research Institutes
- 8.4. Market Analysis, Insights and Forecast – By Application
- 8.4.1. Drug Discovery
- 8.4.2. Disease Diagnosis
- 8.4.3. Teleconsultation
- 8.4.4. Training & Education
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Digital Pathology Market Analysis (USD Billion), Insights and Forecast, 2022-2029
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Scanners
- 9.2.2. Software
- 9.2.3. Communication Systems
- 9.2.4. Storage Systems
- 9.3. Market Analysis, Insights and Forecast – By End Use
- 9.3.1. Pharmaceutical & Biotechnology Companies
- 9.3.2. Hospitals and Reference Laboratories
- 9.3.3. Academic & Research Institutes
- 9.4. Market Analysis, Insights and Forecast – By Application
- 9.4.1. Drug Discovery
- 9.4.2. Disease Diagnosis
- 9.4.3. Teleconsultation
- 9.4.4. Training & Education
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Hamamatsu Photonics, Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Koninklijke Philips N.V.
- 10.6. Olympus Corporation
- 10.7. F. Hoffmann-La Roche Ltd.
- 10.8. Mikroscan Technologies
- 10.9. Inspirata, Inc.
- 10.10. Visiopharm A/S
- 10.11. Huron Digital Pathology
- 10.12. 3DHISTECH Ltd.
- 10.13. ContextVision AB.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
